Evidence map›Paper›PMID 28389563›Full record

ArticleThe Journal of biological chemistry2017

Structure of the WipA protein reveals a novel tyrosine protein phosphatase effector from

Nikos Pinotsis, Gabriel Waksman

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Phosphoproteome-derived peptide libraries for deep specificity profiling of phosphatases and phospholyases.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The Journal of biological chemistry · 2018
    Article
  9. Article
  10. Identification of Conserved ABC Importers Necessary for Intracellular Survival ofFrontiers in cellular and infection microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nikos PinotsisFrom the Department of Biological Sciences, Institute of Structural and Molecular Biology, Birkbeck, Malet Street, WC1E 7HX London, United Kingdom and.ORCID 0000-0002-5096-257X
Gabriel WaksmanFrom the Department of Biological Sciences, Institute of Structural and Molecular Biology, Birkbeck, Malet Street, WC1E 7HX London, United Kingdom and g.waksman@ucl.ac.uk g.waksman@mail.cryst.bbk.ac.uk.ORCID 0000-0003-0708-2726

Funding

European Research Council 321630
6 · The paper itself

Abstract

Legionnaires' disease is a severe form of pneumonia caused by the bacterium

Indexed as

Bacterial ProteinsLegionella pneumophilaMolecular ChaperonesProtein MultimerizationProtein Structure, QuaternaryProtein Structure, SecondaryProtein Tyrosine PhosphatasesVirulence FactorsBacterial ProteinsMolecular ChaperonesProtein Tyrosine PhosphatasesVirulence Factorscoiled-coilcrystal structureenzyme kineticsLegionella effectorMichaelis-Mentenphosphatasephosphoesterase foldtyrosine phosphatasetyrosine-protein phosphatase (tyrosine phosphatase)

Identifiers

PMID28389563
PMCPMC5454105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.